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Differential Myokine Expression in a Model for Myotonic 
Dystrophy Type I
Figure 2: RNA-seq from this previous study revealed broad 
changes to gene expression in CUG960 +dox mice. Gene 
expression changes between control (CUG960 – dox or TRE 
+dox) and repeat-expressing (CUG960 + dox) mice at 12 
weeks are displayed. Events changed in CUG960 +dox mice 
relative to both controls were considered for additional 
analysis.
Introduction 
We would like to thank Dr. April Wynn for allowing us to 
use her resources to conduct our experiments.
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We found 14 putative myokines that show differential 
expression in the repeat expressing mice and designed 
primers for those myokines that will continue to be 
optimized. The results from the data suggest optimization 
of the experimental primer designed for the Cx3cl gene 
as well as internal controls for the Rpl41 and Actb genes. 
The developed primers will be used to validate 
differential expression levels of these myokines using 
quantitative RT-PCR. Validated myokines will be 
assessed in unaffected and DM1 human myoblast cell 
lines to determine the contribution of these myokines to 
the skeletal muscle phenotype in DM1.
Conclusion and Future Works
• Morriss, G. et al. (2018) ‘Mechanisms of skeletal 
muscle wasting in a mouse model for myotonic 
dystrophy type 1’, Human Molecular Genetics, vol.27, 
no. 16, pp. 2789 – 2804.
• Terry, E. et al. (2018) ‘ Transcriptional profiling reveals 
extraordinary diversity among skeletal muscle tissues’, 
eLife.
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The overall goal of this project is to determine the 
contribution of altered myokine expression to 
muscle wasting in DM1. For this semester, we 
focused on optimization of our previously 
designed primers customary for myokines that 
display significant differential expression at 6, 12, 
and 20 weeks of repeat expression including the 
Cx3cl, Cxcl10, and Gdf5 genes found in previous 
studies.
Objective
These RNA-seq tracks were used to view exons that are 
displayed in all isoforms. Above the tracks, I was able to find 
the location of the desired gene and its sequence to plug into 




Primers were designed complementary to each putative myokine 
through the NCBI tool Primer BLAST. Each myokine was 
designated 3 suitable primers for variation. Specified regions with 
constitutive exons were chosen to allow consideration of overall 
expression levels. These primer pairs are for the Cx3cl3 gene.
RT-PCR detection for two primer sets designed for the Rpl41
gene, one for the Actb gene, and one for the Cx3cl gene. 1+ 
and 2+ represent two samples of cDNA used for each primer 
set.
Figure 7: 2% agarose gel composed of 2 g agarose in 100 
mL 1x TAE (Tris-Acetate-EDTA). The dyed PCR products 
were then loaded into the gel and run in an electrophoresis 
chamber at 100V for approximately 1 hour in a 1X TAE 
buffer solution. A Q5 Hot Start High-Fidelity 2X Master Mix 
was used. Denaturation began at 98oC, annealing at 60oC, 




Myotonic dystrophy type 1 (DM1) is a multi-systemic 
disease resulting in severe muscle weakening and 
wasting. Expanded CUG RNA expression in the DMPK 
3’ untranslated region leads to the DM1 muscle wasting 
phenotype though it is unclear the direct mechanisms that 
generate muscle wasting.
Figure 3: RNA-seq data for the Cx3cl gene at 20 weeks based on custom 
tracks found in a previous study.
Figure 4: Using BioVenn, a comparison of RNA-seq data 
between two previous studies, one focusing on putative 
myokines that were expressed in skeletal muscle (green) 
and the other representing differential gene expression 
during muscle wasting (pink), was used to find differentially 
regulated genes that overlapped in a 20-week period to find 
our targets. 
Figure 5: Based on this comparison, 14 genes were found to overlap at 20 weeks 
Figure 6: These primer pairs were designed for the Cx3cl3 gene.
Figure 1: In a previous study (Morriss, et al.), a mouse line 
was generated containing a tet-inducible transgene 
(TREDT960I) that contained 960 CTG repeats in the context 
of human DMPK exons 11-15.
